A recent announcement by the prediction market company Kalshi to accept bets on U.S. Food and Drug Administration (FDA) approvals and clinical trial outcomes has reignited concerns about the potential misuse of insider information in financial trading. The platform intends to offer "event contracts" focused on specific drug development milestones rather than overall company stock performance. Kalshi plans to restrict participation to those who disclose their employers and bar individuals working at pharmaceutical companies or having access to unblinded trial data. Betting will commence only after trial enrollment has closed to mitigate risks of insider trading.
Kalshi argues that these markets provide greater transparency to both competitors and the public about critical industry developments. The company's enforcement director, Robert DeNault, emphasized that the scope of relevant insider knowledge remains narrow, allowing for targeted monitoring of high-risk individuals. Kalshi's approach extends beyond pharmaceuticals; recently, it froze the account of Donald Trump’s long-time teleprompter operator following allegations the individual used insider information about the president’s speeches to place bets on their content.
This preventive policing contrasts with concerns about broader market conduct in Washington. Some members of Congress reportedly engage in trading activities influenced by their actions in office. Meanwhile, anonymous accounts on offshore trading platforms closely linked to political developments, including conflict-related events such as the Iran attack and April ceasefire, have reportedly generated significant profits.
Additionally, Trump Media & Technology Group (TMTG), a family-controlled social media entity, has explored charging traders as much as $100,000 a month for expedited access to President Trump’s posts on Truth Social. This initiative has been framed as a premium information service, citing prior instances where Trump’s social media activity affected financial markets, including stock and oil prices. While resembling high-speed data feeds used by hedge funds, the move raises new concerns over the commodification of government-related information. Some companies may feel compelled to subscribe to avoid competitive disadvantages amid a White House perceived to value loyalty.
Meanwhile, regulatory enforcement has noticeably declined under the current administration. The Commodity Futures Trading Commission (CFTC), which handles suspicious trading referred by platforms like Kalshi, saw cases drop from 58 in the final full fiscal year of the previous administration to just 13 in fiscal year 2025. The Securities and Exchange Commission (SEC) also reported a decrease in insider trading and market manipulation cases, from 54 to 48, alongside a 22 percent decline in total enforcement actions.
Despite assurances from leaders of both agencies about maintaining "vigorous oversight" and "meaningful investor protection," prosecutions for abuses related to prediction markets remain limited. To date, only two individuals—a low-ranking soldier accused of misusing classified information about a military operation in Venezuela and a Google engineer charged with betting on search engine trends—have faced legal action. Both are contesting the charges. Trump’s teleprompter operator has not been formally charged.
Experts note that while prediction market providers employ advanced surveillance and participant screening, the absence of consistent government prosecution may embolden others to exploit insider knowledge. As prediction markets expand into new domains, the challenge of preventing illicit trading based on privileged information is expected to grow.